Literature DB >> 9415285

The use of mRNA differential display for discovery of novel therapeutic targets in cardiovascular disease.

X Wang1, G Z Feuerstein.   

Abstract

Recent advances in molecular biology techniques have provided powerful tools for discovery of novel genes relevant to both biological and pathological processes. mRNA differential display is an emerging technique for novel gene discovery and it has been successfully applied to many physiological and pathological conditions including normal development, cell differentiation, cancer, cardiovascular disease, inflammation and CNS disorders. In the present work, we briefly illustrate the critical procedure and highlight most recent technical improvements and modifications of this technology. Based upon the successful applications of this technique in cardiovascular research, it may provide a valuable and powerful investigational tool for the identification of novel therapeutic targets in cardiovascular diseases.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9415285     DOI: 10.1016/s0008-6363(97)00169-7

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  4 in total

1.  Differential display: a critical analysis.

Authors:  Dana R Crawford; John C Kochheiser; Gary P Schools; Sharon L Salmon; Kelvin J A Davies
Journal:  Gene Expr       Date:  2002

Review 2.  The genomics of cardiovascular disorders: therapeutic implications.

Authors:  P Ferrari; G Bianchi
Journal:  Drugs       Date:  2000-05       Impact factor: 9.546

Review 3.  Applications of differential-display reverse transcription-PCR to molecular pathogenesis and medical mycology.

Authors:  J Sturtevant
Journal:  Clin Microbiol Rev       Date:  2000-07       Impact factor: 26.132

4.  Construction and characterization of a cDNA library from wheat infected with Fusarium graminearum Fg 2.

Authors:  Khaled Al-Taweel; W G Dilantha Fernando; Anita L Brûlé-Babel
Journal:  Int J Mol Sci       Date:  2011-01-18       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.